2273. Outcomes of Trimethoprim/Sulfamethoxazole as Definitive Therapy for Urinary Tract Infections with Multi-Drug-Resistant Enterobacteriaceae

BACKGROUND: Trimethoprim/Sulfamethoxazole (TMP/SMX) is not routinely employed for urinary tract infections (UTI) with multi-drug-resistant organisms (MDRO) due to paucity of effectiveness data, concerns regarding inadequate urinary penetration, and risk of adverse effects. We describe our experience...

Descripción completa

Detalles Bibliográficos
Autores principales: Adhi, Fatima, Dubrovskaya, Yanina, Cytryn, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810461/
http://dx.doi.org/10.1093/ofid/ofz360.1951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810461/
http://dx.doi.org/10.1093/ofid/ofz360.1951

Ejemplares similares